echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAMA Neurology: Application of Next Generation Cerebrospinal Fluid Genome Sequencing Technology in Tumor Detection

    JAMA Neurology: Application of Next Generation Cerebrospinal Fluid Genome Sequencing Technology in Tumor Detection

    • Last Update: 2021-12-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com







    • In these two studies, 130 participants were included (median [interquartile range] age, 57.



      Literature source: Gu W, Rauschecker AM, Hsu E, et al.
      Detection of Neoplasms by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid [published online ahead of print, 2021 Sep 13].
      JAMA Neurol.
      2021;e213088.
      doi:10.
      1001/ jamaneurol.
      2021.
      3088 doi:10.
      1001/jamaneurol.
      2021.
      3088

      leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.